North East and North Cumbria
ICS Formulary
ICS Formulary
4 Central nervous system
04-02-01 Antipsychotic Drugs
For more information on prescribing antipsychotics in primary care see the North of Tyne, Gateshead and North Cumbria APC Information leaflet prepared by CNTW or the TEWV Medicines Optimisation Interactive Guide (as appropriate):
Antipsychotic Drugs – Prescribing & Monitoring in Adults - Information for Primary Care
TEWV Medicines Optimisation Interactive Guide
Links
MHRA Drug Safety Alert (Feb 2015): Drugs and driving: blood concentration limits set for certain drugs- MHRA Drug Safety Alert (Oct 2017): Clozapine: reminder of potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus
- MHRA Drug Safety Update (Aug 2020): Clozapine and other antipsychotics: monitoring blood concentrations for toxicity
- MHRA Drug Safety Update (December 2023): Aripiprazole (Abilify and generic brands): risk of pathological gambling
- MHRA Drug Safety Update (Nov 2013): Risperidone and paliperidone: risk of intraoperative floppy iris syndrome in patients undergoing cataract surgery
- MHRA Drug Safety Update Dec 2021: Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium
NENC Palliative and End of Life Care Symptom Control Guidelines- NICE CG103: Delirium
- NICE CG178: Psychosis and schizophrenia in adults: prevention and management
- NICE NG10: Violence and aggression: short-term management in mental health, health and community settings
- NICE NG11: Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges
- NICE NG62: Cerebral palsy in under 25s: assessment and management
- NICE TA213: Aripiprazole for the treatment of schizophrenia in people aged 15 -17 years
- NICE TA292: Bipolar disorder (children) - aripiprazole
- North East and North Cumbria ICB - Clozapine supporting guidance for primary care
- North of Tyne, Gateshead and North Cumbria - Antipsychotic Leaflet
- NTAG - Lurasidone Treatment Appraisal: Decision Summary
- TEWV - Medicines Optimisation – Interactive Guide
- TEWV Guidelines
- TEWV High Dose Antipsychotic Treatment (HDAT)
- TEWV Rapid Tranquilisation Policy
- TEWV Safe Transfer of Prescribing Guidance